Dr. Christine Klaus

Dr. Christine Klaus is a Senior Life Science Consultant at BridgingIT since February 2023, with previous roles as a Regulatory Affairs Manager CMC at HENNIG ARZNEIMITTEL GmbH & Co. KG and Co-Founder and designated CEO of PolyGlyco (GbR). As a postdoctoral fellow and group leader at the Institute of Reconstructive Neurobiology, University of Bonn, Dr. Klaus led projects on neurodegenerative diseases while overseeing a team of scientists. Academic achievements include a PhD in Biomedical Sciences from the University of Bonn and a post-graduate award in Regulatory Affairs with distinction. Dr. Klaus has extensive research experience across various institutes, focusing on neurobiology and regulatory affairs, supported by a strong educational background in biological sciences and neurosciences.